News, Announcements, & Opportunities

CIRP Annual Meeting

The National Cancer Institute (NCI) will host the Co-clinical Imaging Research Resource Program (CIRP) Annual Virtual Meeting 2023. Join us on May 3-4, 2023 via Webex Meeting held by NCI to learn about how quantitative imaging methods are optimized to improve the quality of imaging results for co-clinical trials of adult and pediatric cancers.

Dr. Pete Nelson named vice president of Precision Oncology (FHCC internal link)

Effective March 1, 2023, Dr. Pete Nelson assumed the role of vice president of Precision Oncology and director of the Sloan Precision Oncology Institute. He will also become the inaugural holder of the Stuart and Molly Sloan Precision Oncology Institute Chair.

CIRP Associate Member Opportunity

CIRP invites NCI and NIH supported academic investigators with expertise in animal models, co-clinical trials, quantitative imaging, and informatics to join the CIRP network as associate members.  The associate members will participate alongside CIRP investigators to contribute the developement of consensus on important co-clinical imaging issues,  expand the scientific scope of CRIP, and accelerate dissemination of CIRP resources.

New computational tools widen horizons for liquid biopsies 

Methods allow scientists to use gene regulation patterns to detect cancer subtype in cell-free DNA.

FHIND Gathering

The first 2023 meeting of FHIND investigators will showcase the scope of cutting-edge diagnostic research at Fred Hutch and identify tools and resources needed to best support precision oncology advancement.

Stat News: Experts discuss NEJM colorectal screening paper

Ruth Etzioni comments on the recent colonoscopy screening trial. 
October 14, 2022

Unlocking more information from liquid biopsies

Dr. Gavin Ha receives $1.5M NIH Director’s New Innovator Award for creative young scientists with high-risk, high-reward projects.
October 3, 2022

Etzioni receives R35 award to study the data/evidence divide

The Outstanding Investigator Award (OIA) will will provide long-term support for Ruth's work to investigate accuracy of multi-cancer liquid and other new technology.
October 6, 2022

An Innovative Partnership to Tackle CML

The Radich Lab partners with the Max Foundation to reach patients across the globe.